Viatris Inc. (VTRS)
NASDAQ: VTRS · Real-Time Price · USD
13.15
-0.14 (-1.05%)
Mar 24, 2026, 9:31 AM EDT - Market open
Viatris Revenue
In the year 2025, Viatris had annual revenue of $14.30B, down -2.98%. Viatris had revenue of $3.70B in the quarter ending December 31, 2025, with 4.97% growth.
Revenue (ttm)
$14.30B
Revenue Growth
-2.98%
P/S Ratio
1.07
Revenue / Employee
$476,663
Employees
30,000
Market Cap
15.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 14.30B | -439.40M | -2.98% |
| Dec 31, 2024 | 14.74B | 439.40M | 3.07% |
| Dec 31, 2023 | 14.30B | -439.40M | -2.98% |
| Dec 31, 2022 | 14.74B | -687.60M | -4.46% |
| Dec 31, 2021 | 15.43B | 3.48B | 29.14% |
| Dec 31, 2020 | 11.95B | 445.50M | 3.87% |
| Dec 31, 2019 | 11.50B | 66.60M | 0.58% |
| Dec 31, 2018 | 11.43B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 17.26B |
| Haleon | 14.85B |
| Zoetis | 9.47B |
| Elanco Animal Health | 4.72B |
| Dr. Reddy's Laboratories | 3.85B |
| United Therapeutics | 3.18B |
| Neurocrine Biosciences | 2.86B |
| Hims & Hers Health | 2.35B |
VTRS News
- 1 day ago - Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD) - PRNewsWire
- 5 days ago - Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030 - PRNewsWire
- 11 days ago - Viatris settles lawsuit over use of woman's 'immortal' cells to power drug research - Reuters
- 20 days ago - These S&P 500 stocks are falling the hardest on Tuesday - Market Watch
- 24 days ago - AI Is Sliding and Everything Else Has Run Up. Here Are 6 Stocks That Look Like Buys. - Barrons
- 25 days ago - Viatris Inc. (VTRS) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 25 days ago - Viatris forecasts 2026 profit below estimates on India manufacturing woes - Reuters
- 26 days ago - Viatris Reports Fourth-Quarter and Full-Year 2025 Financial Results - PRNewsWire